BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jing L, Ott M, Church CD, Kulikauskas RM, Ibrani D, Iyer JG, Afanasiev OK, Colunga A, Cook MM, Xie H, Greninger AL, Paulson KG, Chapuis AG, Bhatia S, Nghiem P, Koelle DM. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas. Cancer Immunol Res 2020;8:648-59. [PMID: 32179557 DOI: 10.1158/2326-6066.CIR-19-0647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Church C, Pulliam T, Longino N, Park SY, Smythe KS, Makarov V, Riaz N, Jing L, Amezquita R, Campbell JS, Gottardo R, Pierce RH, Choi J, Chan TA, Koelle DM, Nghiem P. Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma. J Immunother Cancer 2022;10:e005328. [DOI: 10.1136/jitc-2022-005328] [Reference Citation Analysis]
2 Koelle DM, Dong L, Jing L, Laing KJ, Zhu J, Jin L, Selke S, Wald A, Varon D, Huang ML, Johnston C, Corey L, Posavad CM. HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens. Front Immunol 2022;13:867962. [PMID: 35432373 DOI: 10.3389/fimmu.2022.867962] [Reference Citation Analysis]
3 Kortekaas Krohn I, Aerts JL, Breckpot K, Goyvaerts C, Knol E, Van Wijk F, Gutermuth J. T-cell subsets in the skin and their role in inflammatory skin disorders. Allergy 2022;77:827-42. [PMID: 34559894 DOI: 10.1111/all.15104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fisher LE, Kämmerling L, Alexander MR, Ghaemmaghami AM. Immune-instructive materials as new tools for immunotherapy. Curr Opin Biotechnol 2021;74:194-203. [PMID: 34959210 DOI: 10.1016/j.copbio.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Vitiello GAF, Ferreira WAS, Cordeiro de Lima VC, Medina TDS. Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment. Front Immunol 2021;12:782852. [PMID: 34925363 DOI: 10.3389/fimmu.2021.782852] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Gehrcken L, Sauerer T, Schaft N, Dörrie J. T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options. Int J Mol Sci 2021;22:8679. [PMID: 34445385 DOI: 10.3390/ijms22168679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Finton KAK, Brusniak MY, Jones LA, Lin C, Fioré-Gartland AJ, Brock C, Gafken PR, Strong RK. ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery. Front Immunol 2021;12:658372. [PMID: 33986749 DOI: 10.3389/fimmu.2021.658372] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Nghiem P, Bhatia S, Lipson EJ, Sharfman WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM, Reddy SA, Boulmay BC, Riker A, Burgess MA, Hanks BA, Olencki T, Kendra K, Church C, Akaike T, Ramchurren N, Shinohara MM, Salim B, Taube JM, Jensen E, Kalabis M, Fling SP, Homet Moreno B, Sharon E, Cheever MA, Topalian SL. Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. J Immunother Cancer 2021;9:e002478. [PMID: 33879601 DOI: 10.1136/jitc-2021-002478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci 2020;21:E5394. [PMID: 32751327 DOI: 10.3390/ijms21155394] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
10 Zhao B, Hui X, Jiao L, Bi L, Wang L, Huang P, Yang W, Yin Y, Jin S, Wang C, Zhang X, Xu L. A TCM Formula YYWY Inhibits Tumor Growth in Non-Small Cell Lung Cancer and Enhances Immune-Response Through Facilitating the Maturation of Dendritic Cells. Front Pharmacol 2020;11:798. [PMID: 32595493 DOI: 10.3389/fphar.2020.00798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]